• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Bessa, A., Osman, E., Seddik, A., Tagelden, H. (2022). PREVALANCE OF DIABETIC RETINOPATHY AMONG DIABETIC PATIENTS WITH VARIABLE GLYCOSYLATED HEMOGLOBIN VALUES. ALEXMED ePosters, 4(4), 23-24. doi: 10.21608/alexpo.2022.171682.1501
Amr Bessa; Ehab Osman; Ahmed Metwally Seddik; Hossam Elhag Mohamed Sleim Tagelden. "PREVALANCE OF DIABETIC RETINOPATHY AMONG DIABETIC PATIENTS WITH VARIABLE GLYCOSYLATED HEMOGLOBIN VALUES". ALEXMED ePosters, 4, 4, 2022, 23-24. doi: 10.21608/alexpo.2022.171682.1501
Bessa, A., Osman, E., Seddik, A., Tagelden, H. (2022). 'PREVALANCE OF DIABETIC RETINOPATHY AMONG DIABETIC PATIENTS WITH VARIABLE GLYCOSYLATED HEMOGLOBIN VALUES', ALEXMED ePosters, 4(4), pp. 23-24. doi: 10.21608/alexpo.2022.171682.1501
Bessa, A., Osman, E., Seddik, A., Tagelden, H. PREVALANCE OF DIABETIC RETINOPATHY AMONG DIABETIC PATIENTS WITH VARIABLE GLYCOSYLATED HEMOGLOBIN VALUES. ALEXMED ePosters, 2022; 4(4): 23-24. doi: 10.21608/alexpo.2022.171682.1501

PREVALANCE OF DIABETIC RETINOPATHY AMONG DIABETIC PATIENTS WITH VARIABLE GLYCOSYLATED HEMOGLOBIN VALUES

Article 3, Volume 4, Issue 4, December 2022, Page 23-24  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2022.171682.1501
View on SCiNiTO View on SCiNiTO
Authors
Amr Bessa1; Ehab Osman2; Ahmed Metwally Seddik2; Hossam Elhag Mohamed Sleim Tagelden email 2
1Ophthalmology Department, Faculty of Medicine, Alexandria University, Egypt
2Department of Ophthalmology, Faculty of Medicine, Alexandria University
Abstract
Introduction
Diabetes mellitus (DM) is a growing global health issue and the most common endocrine disorder where the body does not either produce enough insulin or has an insulin resistance. Diabetic retinopathy (DR), which is a common complication in type 1 and type 2 diabetes, remains as a leading cause of preventable sight loss. The most relevant risk factors are the duration of diabetes, poor glycaemic control (high HbA1c) and hypertension.
Classification and grading of DR depends on signs of increasing severity that can be visualized by ophthalmoscope, ranked into a scale from no retinopathy to different stages of non-proliferative disease then advanced PDR.
Determination of the stage of DR severity is essential for assessment of progression risk, treatment modalities, and approving suitable follow up interval. Fundus photography, with or without pupillary dilation, is a technique for detecting documenting the severity of the diabetes.
Glycated hemoglobin (HbA1c) is a clinical test for mean blood glucose estimation. It is widely used to diagnose diabetes and for treatment efficacy monitoring.
Keywords
Diabetic retinopathy; Glycosylated Hemoglobin; HbA1c
Supplementary Files
download 1501 Hossam Elhag Mohamed Sleim Tagelden.pdf
Statistics
Article View: 139
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.